Showing 1 posts of 1 posts found.
Steve Hobbs has been appointed chief business development officer for The Polyhedra Group. Hobbs has over 30 years’ international experience …
London secures major investment to accelerate healthcare innovation
People with severe mental illness more likely to die early from cardiovascular disease, report finds
Yourgene wins Australian approval for chemotherapy toxicity screening assay
ProBioGen secures extended GMP authorisation for viral manufacturing facility
PlaqueTec coronary disease trial reaches 100 patients across eight NHS centres